Nexus Pharma Co., Ltd.

Nexus Pharma Co., Ltd. company information, Employees & Contact Information

Nexus Pharma co., ltd. works to bring the global pharmaceutical community closer together. From small businesses to major pharmaceutical manufacturers, we bring you the highest quality of every pharmaceutical product available in Korea.

Company Details

Employees
39
Founded
-
Address
6th Floor, Ch Building, 71, Gonghangdaero 45gil,, Gangseogu,korea, Republic Of
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Seoul, Seoul
Looking for a particular Nexus Pharma Co., Ltd. employee's phone or email?

Nexus Pharma Co., Ltd. Questions

News

Nexus Pharmaceuticals Launches Tranexamic Acid - Business Wire

Nexus Pharmaceuticals Launches Tranexamic Acid Business Wire

On an investment spree, Lilly will spend $3B to expand newly acquired injectables plant in Wisconsin - Fierce Pharma

On an investment spree, Lilly will spend $3B to expand newly acquired injectables plant in Wisconsin Fierce Pharma

Nexus Pharmaceuticals Receives FDA Approval for Tacrolimus Injection - Business Wire

Nexus Pharmaceuticals Receives FDA Approval for Tacrolimus Injection Business Wire

Eli Lilly to acquire manufacturing facility from Nexus Pharma - Reuters

Eli Lilly to acquire manufacturing facility from Nexus Pharma Reuters

Price tag for Nexus Pharmaceuticals plant sale to Lilly approached $1 billion - BizTimes - Milwaukee Business News

Price tag for Nexus Pharmaceuticals plant sale to Lilly approached $1 billion BizTimes - Milwaukee Business News

With $27B plan to build 4 new plants, Eli Lilly doubles down on US drug manufacturing - Fierce Pharma

With $27B plan to build 4 new plants, Eli Lilly doubles down on US drug manufacturing Fierce Pharma

Nexus Pharmaceuticals Opens State-of-the-Art Manufacturing Facility - Contract Pharma

Nexus Pharmaceuticals Opens State-of-the-Art Manufacturing Facility Contract Pharma

Nexus Pharmaceuticals Sterile Injectable Production Facility, Wisconsin - Pharmaceutical Technology

Nexus Pharmaceuticals Sterile Injectable Production Facility, Wisconsin Pharmaceutical Technology

Lilly to buy injectable drug plant in manufacturing ramp-up - BioPharma Dive

Lilly to buy injectable drug plant in manufacturing ramp-up BioPharma Dive

Firm tackles US drug shortages during COVID with Wisconsin plant - CIDRAP

Firm tackles US drug shortages during COVID with Wisconsin plant CIDRAP

Wisconsin family-owned manufacturer acquired by pharma giant Eli Lily - WISN

Wisconsin family-owned manufacturer acquired by pharma giant Eli Lily WISN

Nexus Pharmaceuticals sells Pleasant Prairie facility to pharmaceutical giant Eli Lilly - BizTimes - Milwaukee Business News

Nexus Pharmaceuticals sells Pleasant Prairie facility to pharmaceutical giant Eli Lilly BizTimes - Milwaukee Business News

Six Payer Trends Shaping Market Access in 2025 - Fierce Pharma

Six Payer Trends Shaping Market Access in 2025 Fierce Pharma

Nexus Pharmaceuticals Receives FDA Approval for Methylene Blue Injection, USP - Business Wire

Nexus Pharmaceuticals Receives FDA Approval for Methylene Blue Injection, USP Business Wire

Eli Lilly inks deal to acquire Nexus manufacturing plant in Wisconsin as Mounjaro and Zepbound shortages drag on - Fierce Pharma

Eli Lilly inks deal to acquire Nexus manufacturing plant in Wisconsin as Mounjaro and Zepbound shortages drag on Fierce Pharma

Nexus Pharmaceuticals LLC Announces Appointment of New Board Members - Business Wire

Nexus Pharmaceuticals LLC Announces Appointment of New Board Members Business Wire

High-flying Eli Lilly plots $15B share buyback campaign - Fierce Pharma

High-flying Eli Lilly plots $15B share buyback campaign Fierce Pharma

Nexus Pharmaceuticals Announces Usman Ahmed as President and Chief Executive Officer - Business Wire

Nexus Pharmaceuticals Announces Usman Ahmed as President and Chief Executive Officer Business Wire

Sterile drug maker Nexus launches $250M U.S. manufacturing project - Fierce Pharma

Sterile drug maker Nexus launches $250M U.S. manufacturing project Fierce Pharma

Nexus Pharmaceuticals, Inc. Receives Successful FDA Inspection of Pharmaceutical Manufacturing Facility in Pleasant Prairie, Wisconsin - Business Wire

Nexus Pharmaceuticals, Inc. Receives Successful FDA Inspection of Pharmaceutical Manufacturing Facility in Pleasant Prairie, Wisconsin Business Wire

Nexus Pharmaceuticals Launches Baclofen Injection, USP - Business Wire

Nexus Pharmaceuticals Launches Baclofen Injection, USP Business Wire

Lilly acquires Nexus plant to meet GLP-1 demand - BioProcess International

Lilly acquires Nexus plant to meet GLP-1 demand BioProcess International

Nexus Pharmaceuticals aims to grow Pleasant Prairie footprint as it adds drug lines - WisBusiness

Nexus Pharmaceuticals aims to grow Pleasant Prairie footprint as it adds drug lines WisBusiness

Moderna discusses COVID-19 vaccine manufacturing with Nexus Pharmaceuticals -sources - Reuters

Moderna discusses COVID-19 vaccine manufacturing with Nexus Pharmaceuticals -sources Reuters

Nexus Pharma Barred From Suing Drug Compounder Under State Law - Bloomberg Law News

Nexus Pharma Barred From Suing Drug Compounder Under State Law Bloomberg Law News

University of Wisconsin-Parkside Athletics receives record-breaking donation from Omair Ahmed - Universities of Wisconsin

University of Wisconsin-Parkside Athletics receives record-breaking donation from Omair Ahmed Universities of Wisconsin

Nexus Wins Patent Litigation for Injectable Cyclophosphamide, Paving Way for Generic - Business Wire

Nexus Wins Patent Litigation for Injectable Cyclophosphamide, Paving Way for Generic Business Wire

Nexus to build $250M manufacturing facility in Wisconsin - BioPharma Dive

Nexus to build $250M manufacturing facility in Wisconsin BioPharma Dive

Family chemistry: Nexus Pharmaceuticals brings new thinking to drug industry - BizTimes - Milwaukee Business News

Family chemistry: Nexus Pharmaceuticals brings new thinking to drug industry BizTimes - Milwaukee Business News

Nexus Pharmaceuticals Launches Methylene Blue Injection - BioSpace

Nexus Pharmaceuticals Launches Methylene Blue Injection BioSpace

FDA completes inspection of Nexus’ manufacturing facility in US - Pharmaceutical Business review -

FDA completes inspection of Nexus’ manufacturing facility in US Pharmaceutical Business review -

Germany looks to South Africa for cannabis supply: Enua partners with Nexus Pharma - IOL

Germany looks to South Africa for cannabis supply: Enua partners with Nexus Pharma IOL

Nexus Pharmaceuticals, Inc. Receives FDA Approval for EMERPHED® (ephedrine sulfate injection) Pre-Filled Syringe - Business Wire

Nexus Pharmaceuticals, Inc. Receives FDA Approval for EMERPHED® (ephedrine sulfate injection) Pre-Filled Syringe Business Wire

Lilly cranks up outlook, banking on GLP-1 production expansions despite continuing supply squeeze - Fierce Pharma

Lilly cranks up outlook, banking on GLP-1 production expansions despite continuing supply squeeze Fierce Pharma

Lilly to invest $5.3B more on Mounjaro, Zepbound production - FirstWord Pharma

Lilly to invest $5.3B more on Mounjaro, Zepbound production FirstWord Pharma

Entrepreneur of the Year: Mariam Darsot, board chair, retired CEO Nexus Pharmaceuticals - BizTimes - Milwaukee Business News

Entrepreneur of the Year: Mariam Darsot, board chair, retired CEO Nexus Pharmaceuticals BizTimes - Milwaukee Business News

Exela Wins Jury Trial Over Nexus Patents for Ephedrine Shot - Bloomberg Law News

Exela Wins Jury Trial Over Nexus Patents for Ephedrine Shot Bloomberg Law News

Pharmaceutical Industry Mergers & Acquisitions Roundup - Contract Pharma

Pharmaceutical Industry Mergers & Acquisitions Roundup Contract Pharma

Eli Lilly buying Nexus Pharmaceuticals facility - Crain's Chicago Business

Eli Lilly buying Nexus Pharmaceuticals facility Crain's Chicago Business

Nexus Pharmaceuticals, Inc. Receives Successful FDA Inspection of Pharmaceutical Manufacturing Facility in Pleasant Prairie, Wisconsin - BioSpace

Nexus Pharmaceuticals, Inc. Receives Successful FDA Inspection of Pharmaceutical Manufacturing Facility in Pleasant Prairie, Wisconsin BioSpace

Nexus Pharmaceuticals Receives Patent for EMERPHED® Ready-To-Use Ephedrine Sulfate Injection - Business Wire

Nexus Pharmaceuticals Receives Patent for EMERPHED® Ready-To-Use Ephedrine Sulfate Injection Business Wire

Eli Lilly invests additional $5.3B for production of diabetes, obesity drugs in Indiana - Fierce Pharma

Eli Lilly invests additional $5.3B for production of diabetes, obesity drugs in Indiana Fierce Pharma

Nexus Pharmaceuticals Receives FDA Approval for 0.9% Sodium Chloride Injection - Business Wire

Nexus Pharmaceuticals Receives FDA Approval for 0.9% Sodium Chloride Injection Business Wire

Usman Ahmed at Nexus Pharmaceuticals - Crain's Chicago Business

Usman Ahmed at Nexus Pharmaceuticals Crain's Chicago Business

Nexus Pharmaceuticals Announces Launch of Succinylcholine Chloride Injection, USP - Business Wire

Nexus Pharmaceuticals Announces Launch of Succinylcholine Chloride Injection, USP Business Wire

Nexus Pharmaceuticals, Inc. Announces Approval of Emerphed™ (ephedrine sulfate) Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial) - Business Wire

Nexus Pharmaceuticals, Inc. Announces Approval of Emerphed™ (ephedrine sulfate) Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial) Business Wire

Nexus Pharmaceuticals Receives FDA Approval for Arsenic Trioxide Injection in 10mg per 10mL Vial - BioSpace

Nexus Pharmaceuticals Receives FDA Approval for Arsenic Trioxide Injection in 10mg per 10mL Vial BioSpace

Nexus Pharmaceuticals Announces Launch of Potassium Chloride in Water for Injection - Business Wire

Nexus Pharmaceuticals Announces Launch of Potassium Chloride in Water for Injection Business Wire

Nexus Pharmaceuticals, Inc. Announces Launch of Emerphed™ (ephedrine sulfate) RTU Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial) - BioSpace

Nexus Pharmaceuticals, Inc. Announces Launch of Emerphed™ (ephedrine sulfate) RTU Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial) BioSpace

CDMOs: Challenges & Opportunities in a Big Year of Change - Contract Pharma

CDMOs: Challenges & Opportunities in a Big Year of Change Contract Pharma

Why it is so difficult to break the pharma-doc nexus - Times of India

Why it is so difficult to break the pharma-doc nexus Times of India

Nexus Pharmaceuticals, Inc. Announces Launch of Emerphed™ (ephedrine sulfate) RTU Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial) - Business Wire

Nexus Pharmaceuticals, Inc. Announces Launch of Emerphed™ (ephedrine sulfate) RTU Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial) Business Wire

Nexus Pharmaceuticals gets FDA approval for Emerphed pre-filled syringe - Pharmaceutical Business review -

Nexus Pharmaceuticals gets FDA approval for Emerphed pre-filled syringe Pharmaceutical Business review -

FDA's generic competition push hits Valeant's Isuprel, a price-hike poster child - Fierce Pharma

FDA's generic competition push hits Valeant's Isuprel, a price-hike poster child Fierce Pharma

Dicyclomine HCl Injection, USP- Now Available from Nexus Pharmaceuticals - BioSpace

Dicyclomine HCl Injection, USP- Now Available from Nexus Pharmaceuticals BioSpace

Nexus Pharmaceuticals gets FDA nod for Arsenic Trioxide injection in 10mg per 10mL vial - Pharmaceutical Business review -

Nexus Pharmaceuticals gets FDA nod for Arsenic Trioxide injection in 10mg per 10mL vial Pharmaceutical Business review -

Pharma-Doctor Nexus Part I: Why rules, Code for doctors, drugmakers have failed to curb unethical... - Moneycontrol

Pharma-Doctor Nexus Part I: Why rules, Code for doctors, drugmakers have failed to curb unethical... Moneycontrol

Supreme Court’s Oral Remark Sends Shivers Down Doctor-Pharma Nexus: Here’s What Happened - The420.in

Supreme Court’s Oral Remark Sends Shivers Down Doctor-Pharma Nexus: Here’s What Happened The420.in

South Africa leaves R30 billion to go up in smoke - businesstech.co.za

South Africa leaves R30 billion to go up in smoke businesstech.co.za

Germany SA Cannabis Supply | Enua and Nexus Pharma Partnership - Joburg ETC

Germany SA Cannabis Supply | Enua and Nexus Pharma Partnership Joburg ETC

Song Ji Hyo Signs With New Agency - Soompi

Song Ji Hyo Signs With New Agency Soompi

Top Nexus Pharma Co., Ltd. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant